25 results
8-K
EX-10.1
BIAF
BioAffinity Technologies Inc
5 Jun 24
Departure of Directors or Certain Officers
4:10pm
to the Participant, or other conduct by the Participant that is detrimental to the business or reputation of the Company. The Committee may also
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
facing our business. The following factors could result in harm to our business, reputation, revenue, financial results, and prospects, among other … tests do not perform as expected, our operating results, reputation, and business will suffer.
We may experience delays in development, introduction
POS AM
g6b8 3kaanp0p6dba
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
424B5
ze5igp3
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
g9lvo7d1g oor6
7 Mar 24
Prospectus supplement for primary offering
9:57pm
424B5
gm3gqqug8s8w
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
qyh of28aj
16 Nov 23
Shelf registration
5:23pm
8-K
EX-10.8
9u7rejbf1c dk6wuw
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-10.6
kqq03tluiz17g77n
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
DRS
i2qpscwgjgawv
14 Aug 23
Draft registration statement
12:00am
DEF 14A
as5jbi rgibz8ndmw
1 May 23
Definitive proxy
2:55pm
PRE 14A
t5hjxy1ms ibbc
19 Apr 23
Preliminary proxy
9:56pm
10-K
wr5k1ljw9n tp
31 Mar 23
Annual report
3:40pm
424B4
bwpawxd46 s3
2 Sep 22
Prospectus supplement with pricing info
3:25pm